Animal Model Market Size Projected to Garner USD 3.6 Billion by 2032 growing at 18.3% CAGR - Exclusive Report by Acumen Research and Consulting

Author: Acumen Research and Consulting

The Global Animal Model Market Size is predicted to reach USD 3.6 Billion by 2032 from USD 1.9 Billion in 2022, at a CAGR of 6.7% between 2023 and 2032, as per the Acumen Research and Consulting

Animal models refer to non-human organisms, typically animals, used in scientific research to study biological processes, diseases, and test potential therapies or drugs. These models are essential tools in various fields, including biology, medicine, and pharmacology, as they provide valuable insights into human physiology and help researchers understand complex biological mechanisms. Commonly used animal models include mice, rats, zebrafish, and fruit flies, among others.

The market for animal models has been steadily growing over the years due to the increasing demand for preclinical research in drug development, disease modeling, and basic biological research. Pharmaceutical and biotechnology companies heavily rely on animal models to assess the safety and efficacy of potential drug candidates before moving into human clinical trials. Furthermore, the rise in chronic diseases and the need for understanding their underlying mechanisms has driven the demand for more sophisticated and disease-specific animal models.

In recent years, the animal model market has seen innovations in genetic engineering techniques such as CRISPR-Cas9, which enable the creation of customized animal models with specific genetic mutations, mimicking human diseases more accurately. This has further fueled market growth as researchers seek more precise and personalized models for their studies. Additionally, the expansion of academic and research institutions, along with government funding for research projects, has contributed to the overall growth of the animal model market.

Animal Model Market Analysis

Animal Model Market Statistics

  • Global Animal Model Market value was worth USD 1.9 Billion in 2022, with a 6.7% CAGR from 2023 to 2032
  • North America Animal Model Market share occupied around 44% in 2022
  • Asia-Pacific region is expected to expand at the highest CAGR between 2023 and 2032
  • By animal type, the mice segment captured the largest market share in 2022
  • Growing demand for CRISPR/Cas9-based models and gene editing services, propel the Animal Model Market Revenue

Request for a sample of this premium research report@

Animal Model Market Trends

The animal model market is entering an evolving era marked by several significant trends and developments. One of the key shifts is the increasing emphasis on ethical considerations and the exploration of alternative methods to reduce the use of animals in research. This has led to the development of in vitro models, organoids, and advanced computational modeling, which aim to replicate physiological processes and diseases without the need for live animals. As these alternatives become more sophisticated and reliable, they are likely to impact the market by providing researchers with more ethical and cost-effective options.

Another important aspect of the evolving era for the animal model market is the growing focus on personalized medicine and precision research. Researchers are increasingly using genetically engineered animal models, such as mice with specific mutations, to mimic human diseases and responses more accurately. This trend reflects a shift toward tailoring research models to individual patient profiles and therapeutic targets. As a result, the market is likely to see increased demand for genetically modified animal models and services that support their creation and maintenance. Moreover, advances in technologies like CRISPR-Cas9 continue to revolutionize the field, making it easier to create precise and customizable animal models. These developments are expected to drive innovation and competition within the market, ultimately shaping the future of animal modeling and its role in scientific research.

Animal Model Market Segmentation

Acumen Research and Consulting has segmented the global Animal Model Market by animal type, technology, application, end user, and region.

  • By animal type, the industry is categorized into rat, guinea pigs, rabbits, mice, and others.
  • By technology, the market is divided into CRISPR, nuclear transfer, embryonic stem cell injection, and others.
  • By application, the market is classified into basic research, drug discovery and development, and others.
  • By end user, the market is split into academic research institutes, pharma and biotech companies, and others.
  • By region, the market is classified into Asia-Pacific, North America, Europe, Latin America, and the MEA.

Animal Model Market Regional Overview

According to the animal model industry analysis, the Asia-Pacific region is experiencing significant growth in the animal model market in the coming years. Asia-Pacific has witnessed a substantial increase in biomedical research activities in recent years. Many countries in the region are investing heavily in research infrastructure, academia, and healthcare. This growth is particularly notable in countries like China, Japan, South Korea, and India, which have established themselves as key players in pharmaceuticals and biotechnology. As research in these countries expands, the demand for animal models to conduct preclinical studies and understand disease mechanisms has surged, driving the animal model market growth. The Asia-Pacific region offers competitive advantages in terms of lower operating costs for animal research facilities compared to Western counterparts. This cost-effectiveness attracts both academic institutions and pharmaceutical companies looking to conduct extensive research using animal models without straining their budgets. This factor has made the region an attractive destination for outsourcing animal model services, further boosting the market's growth.

Animal Model Market Players

Some of the prominent Animal Model Market companies are Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, genOway S.A., Horizon Discovery Group plc, JANVIER LABS, Trans Genic Inc., Ozgene Pty Ltd., Crown Bioscience, Inc., Ingenious Targeting Laboratory, and Pharmaron.

Click here to buy the Premium Market Research report

Receive our personalized services and customization by clicking here

Mr. Frank Wilson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533